These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27259840)

  • 21. Virulence-suppressing effects of linezolid on methicillin-resistant Staphylococcus aureus: possible contribution to early defervescence.
    Yoshizawa S; Tateda K; Saga T; Ishii Y; Yamaguchi K
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1744-8. PubMed ID: 22290944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Azithromycin in a Mouse Pneumonia Model against Hospital-Acquired Methicillin-Resistant Staphylococcus aureus.
    Yamashita Y; Nagaoka K; Kimura H; Suzuki M; Konno S; Fukumoto T; Akizawa K; Kaku N; Morinaga Y; Yanagihara K
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tedizolid inhibits MUC5AC production induced by methicillin-resistant Staphylococcus aureus in human airway epithelial cells.
    Takeda K; Kaku N; Morinaga Y; Kosai K; Uno N; Imamura Y; Hasegawa H; Miyazaki T; Izumikawa K; Mukae H; Yanagihara K
    J Infect Chemother; 2017 Sep; 23(9):598-603. PubMed ID: 28729052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anti-inflammatory effect of tedizolid on carrageenan-induced footpad edema rat model.
    Isobe N; Chuang VTG; Liu X; Enoki Y; Taguchi K; Matsumoto K
    J Infect Chemother; 2023 Nov; 29(11):1088-1090. PubMed ID: 37453465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.
    Moran GJ; Fang E; Corey GR; Das AF; De Anda C; Prokocimer P
    Lancet Infect Dis; 2014 Aug; 14(8):696-705. PubMed ID: 24909499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linezolid Exerts Greater Bacterial Clearance but No Modification of Host Lung Gene Expression Profiling: A Mouse MRSA Pneumonia Model.
    Chen J; Feng G; Song Y; Wardenburg JB; Lin S; Inoshima I; Otto M; Wunderink RG
    PLoS One; 2013; 8(6):e67994. PubMed ID: 23826353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of pharmacokinetic/pharmacodynamic systems analyses to inform dose selection of tedizolid phosphate.
    Lodise TP; Drusano GL
    Clin Infect Dis; 2014 Jan; 58 Suppl 1():S28-34. PubMed ID: 24343829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
    McCool R; Gould IM; Eales J; Barata T; Arber M; Fleetwood K; Glanville J; Kauf TL
    BMC Infect Dis; 2017 Jan; 17(1):39. PubMed ID: 28061827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linezolid Attenuates Lethal Lung Damage during Postinfluenza Methicillin-Resistant Staphylococcus aureus Pneumonia.
    Verma AK; Bauer C; Yajjala VK; Bansal S; Sun K
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31383747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Puzniak LA; Morrow LE; Huang DB; Barreto JN
    Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cells significantly improved treatment effects of Linezolid on severe pneumonia in a rabbit model.
    Kong D; Liu X; Li X; Hu J; Li X; Xiao J; Dai Y; He M; Liu X; Jiang Y; Cui R; Zhang L; Wang J; Li A; Wang F; Zhang Y; Xiao J; Wang W; Zheng C
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31484796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of Tedizolid and Daptomycin against Methicillin-Resistant Staphylococcus aureus in an
    Smith JR; Yim J; Rice S; Stamper K; Kebriaei R; Rybak MJ
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy of human-simulated epithelial lining fluid exposures of tedizolid, linezolid and vancomycin in neutropenic and immunocompetent murine models of staphylococcal pneumonia.
    Kidd JM; Abdelraouf K; Nicolau DP
    J Antimicrob Chemother; 2019 Apr; 74(4):970-977. PubMed ID: 30561650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potency of SMP-601, a novel carbapenem, in hematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    Kihara R; Yanagihara K; Morinaga Y; Araki N; Nakamura S; Seki M; Izumikawa K; Kakeya H; Yamamoto Y; Tsukamoto K; Kamihira S; Kohno S
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2163-8. PubMed ID: 18391033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of Tedizolid in Methicillin-Resistant Staphylococcus aureus Experimental Foreign Body-Associated Osteomyelitis.
    Park KH; Greenwood-Quaintance KE; Mandrekar J; Patel R
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6568-6572. PubMed ID: 27550347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs.
    Martinez-Olondris P; Rigol M; Soy D; Guerrero L; Agusti C; Quera MA; Li Bassi G; Esperatti M; Luque N; Liapikou M; Filella X; Marco F; de la Bellacasa JP; Torres A
    Crit Care Med; 2012 Jan; 40(1):162-8. PubMed ID: 21926613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological action and clinical effect of tedizolid phosphate (SIVEXTRO
    Mori M; Takase A
    Nihon Yakurigaku Zasshi; 2020; 155(5):332-339. PubMed ID: 32879176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacies of tedizolid phosphate, vancomycin, and daptomycin in a rabbit model of methicillin-resistant Staphylococcus aureus endocarditis.
    Chan LC; Basuino L; Dip EC; Chambers HF
    Antimicrob Agents Chemother; 2015; 59(6):3252-6. PubMed ID: 25801564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linezolid has unique immunomodulatory effects in post-influenza community acquired MRSA pneumonia.
    Bhan U; Podsiad AB; Kovach MA; Ballinger MN; Keshamouni V; Standiford TJ
    PLoS One; 2015; 10(1):e0114574. PubMed ID: 25635685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.